A structured framework for evaluating medical weight loss practices — from GLP-1 prescribing compliance and patient retention cohorts to licensing, payer mix, and SBA deal structures.
Find Weight Loss Clinic Acquisition TargetsAcquiring a medical weight loss clinic in the $1M–$5M revenue range requires evaluating clinical compliance, recurring revenue quality, and provider dependency. With GLP-1 demand reshaping the market and PE rollups accelerating consolidation, disciplined due diligence protects against regulatory exposure and revenue overstatement. Expect EBITDA multiples of 3.5x–6x depending on retention metrics, compliance history, and provider infrastructure.
Validate the sustainability and composition of clinic revenue before advancing negotiations. Focus on recurring program enrollment, payer mix, and normalized EBITDA.
Separate owner compensation from market-rate medical director salary. Identify personal expenses, one-time costs, and non-recurring revenue inflating reported profitability.
Break down revenue between cash-pay, insurance reimbursement, and employer contracts. High cash-pay concentration improves margins but increases churn sensitivity.
Identify month-over-month enrollment growth, seasonal patterns, and revenue per patient. Flag any sharp declines coinciding with drug shortages or competitive entries.
Medical weight loss clinics carry layered compliance obligations. Unresolved licensing issues, prescribing irregularities, or HIPAA gaps can derail deals or create post-close liability.
Confirm all provider licenses are current, DEA registrations are active, and medical director contracts are assignable or replaceable without triggering operational disruption.
Assess documentation of clinical protocols for semaglutide and tirzepatide prescribing. Confirm compounding pharmacy compliance given evolving FDA enforcement on 503B facilities.
Request HIPAA policies, staff training records, and breach incident logs. Pull malpractice carrier history and confirm no open state medical board investigations exist.
Evaluate business transferability by assessing key-person dependency, staff retention risk, and whether patient relationships are institution-bound or owner-dependent.
Request 12–24 month cohort data showing 90-day dropout rates, average program duration, lifetime value per patient, and month-over-month active patient counts.
Confirm credentialed providers have signed non-solicitation agreements. Assess enforceability under state law, particularly for the owner-physician if transitioning out post-close.
Determine whether documented SOPs, intake workflows, and clinical protocols exist independently of the owner. Undocumented processes create key-person risk and integration friction.
Verify the Weight Loss Clinic acquisition qualifies for SBA financing, the purchase price is supportable by the verified cash flow, and the deal structure protects the buyer's downside.
Confirm the Weight Loss Clinic meets SBA 7(a) eligibility requirements: the business is for-profit, U.S.-based, within SBA size standards, and the buyer meets personal financial requirements. Some industries have specific SBA restrictions — verify before LOI.
Model verified normalized EBITDA against projected SBA loan payments at current rates. A $1M SBA 7(a) loan at 10.5% over 10 years costs approximately $13,000/month. The Weight Loss Clinic must generate at least 1.25x debt service coverage after a market-rate manager salary to pass underwriting.
Confirm the seller note is properly subordinated to the SBA loan and goes on 24-month standby as required by SBA rules. If an earnout is included, define exact measurement metrics, time period, and dispute resolution process before signing the purchase agreement.
Before signing a Letter of Intent, request these documents from the seller. Missing or incomplete items are a red flag — not a reason to proceed without them.
Most profitable medical weight loss clinics trade at 3.5x–6x EBITDA. Higher multiples reflect strong patient retention, multiple credentialed providers, clean compliance history, and diversified recurring revenue beyond a single GLP-1 program.
Yes. Weight loss clinics are generally SBA 7(a) eligible. Buyers typically finance 80–90% of the purchase price through SBA debt with a 10–20% seller note or equity rollover, subject to lender underwriting of the practice's cash flow.
Regulatory exposure around GLP-1 prescribing practices and compounding pharmacy relationships is the highest-risk area. FDA enforcement on 503B compounders and evolving telemedicine rules can materially impact revenue and compliance costs post-close.
Request patient cohort data showing retention rates tied to the clinic brand versus the owner-physician. Clinics with documented protocols, multiple providers, and membership-based revenue tend to retain patients through transitions more reliably than solo-provider practices.
More Weight Loss Clinic Guides
DealFlow OS surfaces targets with seller signals and motivation scores — so you know before you start diligence. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers